Evidence map›Paper›PMID 32816823›Full record

ReviewBMJ global health2020

Policy dialogue as a collaborative tool for multistakeholder health governance: a scoping study.

Emilie Robert, Dheepa Rajan, Kira Koch, Alyssa Muggleworth Weaver, Denis Porignon, Valery Ridde

Abstract readReview
In one paragraph

Review in BMJ global health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Who is "anti-science"?Public health in practice (Oxford, England) · 2024
    Article
  12. Article
  13. Article
  14. An ethical analysis of policy dialogues.Health research policy and systems · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Shaping Policy on Chronic Diseases through National Policy Dialogs in CHRODIS PLUS.International journal of environmental research and public health · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Emilie RobertInstitut universitaire SHERPA, CIUSSS du Centre-Ouest-de-l'Île-de-Montréal, Montreal, Quebec, Canada emilierobert.udem@gmail.com.ORCID 0000-0002-2260-1873
Dheepa RajanWorld Health Organization, Geneva, Switzerland.ORCID 0000-0001-8733-0560
Kira KochWorld Health Organization, Geneva, Switzerland.
Alyssa Muggleworth WeaverWorld Health Organization, Geneva, Switzerland.
Denis PorignonWorld Health Organization, Geneva, Switzerland.
Valery RiddeCEPED (French Centre for Population and Development), IRD (French Research Institute for Development) (IRD-Paris Descartes University), Paris, France.ORCID 0000-0001-9299-8266

Funding

World Health Organization 001
6 · The paper itself

Abstract

introductionHealth system governance is the cornerstone of performant, equitable and sustainable health systems aiming towards universal health coverage. Global health actors have increasingly been using policy dialogue (PD) as a governance tool to engage with both state and non-state stakeholders. Despite attempts to frame PD practices, it remains a catch-all term for both health systems professionals and researchers.

methodWe conducted a scoping study on PD. We identified 25 articles published in English between 1985 and 2017 and 10 grey literature publications. The analysis was guided by the following questions: (1) How do the authors define PD? (2) What do we learn about PD practices and implementation factors? (3) What are the specificities of PD in low-income and middle-income countries?

resultsThe analysis highlighted three definitions of policy dialogue: a knowledge exchange and translation platform, a mode of governance and an instrument for negotiating international development aid. Success factors include the participants' continued and sustained engagement throughout all the relevant stages, their ability to make a constructive contribution to the discussions while being truly representative of their organisation and their high interest and stake in the subject. Prerequisites to ensuring that participants remained engaged were a clear process, a shared understanding of the goals at all levels of the PD and a PD approach consistent with the PD objective. In the context of development aid, the main challenges lie in the balance of power between stakeholders, the organisational or technical capacity of recipient country stakeholders to drive or contribute effectively to the PD processes and the increasingly technocratic nature of PD.

conclusionPD requires a high level of collaborative governance expertise and needs constant, although not necessarily high, financial support. These conditions are crucial to make it a real driver of health system reform in countries' paths towards universal health coverage.

Indexed as

Health PolicyPolicy MakingCapacity BuildingHealth PlanningHealth PromotionHumanshealth policyhealth systemshealth systems evaluationreview

Identifiers

PMID32816823
PMCPMC7437973

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.